Literature DB >> 15113853

HPV and histological status of pelvic lymph node metastases in cervical cancer: a prospective study.

K Lukaszuk1, J Liss, I Wozniak, W Sliwinski, J Emerich, C Wojcikowski.   

Abstract

AIMS: The purpose of this prospective study was to describe the incidence and distribution pattern of human papillomavirus (HPV) DNA in intraoperative dissected lymph nodes and to relate this to the pathological confirmation of metastasis.
METHODS: Samples of primary cervical cancer lesions and dissected lymph nodes were obtained from women undergoing surgical treatment. The presence of HPV DNA was detected by the polymerase chain reaction.
RESULTS: Tissue from 79 tumours and 365 lymph nodes was analysed. Metastasis to the lymph nodes was found in 19 cases. Metastasis correlated with the volume of the primary lesion, the depth of cervical and vaginal invasion, and with invasion of the corpus. HPV DNA was found in 60 of the primary lesions and 31 of the lymph nodes. The presence of HPV DNA in the lymph nodes correlated with the volume of the primary lesion and vaginal invasion.
CONCLUSIONS: The incidence of HPV DNA in lymph nodes is twice as high as that of histopathologically confirmed metastases. The risk of the presence of HPV DNA and histopathologically confirmed metastases in lymph nodes is related to certain features of the primary tumour.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15113853      PMCID: PMC1770301          DOI: 10.1136/jcp.2003.009852

Source DB:  PubMed          Journal:  J Clin Pathol        ISSN: 0021-9746            Impact factor:   3.411


  21 in total

1.  Prospective surgical-pathological study of disease-free interval in patients with stage IB squamous cell carcinoma of the cervix: a Gynecologic Oncology Group study.

Authors:  G Delgado; B Bundy; R Zaino; B U Sevin; W T Creasman; F Major
Journal:  Gynecol Oncol       Date:  1990-09       Impact factor: 5.482

2.  Presence of human papilloma virus DNA in pelvic lymph nodes can predict unexpected recurrence of cervical cancer in patients with histologically negative lymph nodes.

Authors:  Y Kobayashi; M Yoshinouchi; G Tianqi; K Nakamura; A Hongo; S Kamimura; Y Mizutani; J Kodama; Y Miyagi; T Kudo
Journal:  Clin Cancer Res       Date:  1998-04       Impact factor: 12.531

3.  Presence of oncogenic HPV DNAs in cervical carcinoma tissues and pelvic lymph nodes associating with proliferating cell nuclear antigen expression.

Authors:  J S Park; K S Rhyu; C J Kim; H S Kim; K T Han; H K Ahn; S J Kim; S E Namkoong
Journal:  Gynecol Oncol       Date:  1996-03       Impact factor: 5.482

4.  Direct sequencing of consensus primer generated PCR fragments of human papillomaviruses.

Authors:  P L Rady; R Chin; I Arany; T K Hughes; S K Tyring
Journal:  J Virol Methods       Date:  1993-08       Impact factor: 2.014

Review 5.  Molecular pathogenesis of cancer of the cervix and its causation by specific human papillomavirus types.

Authors:  H zur Hausen
Journal:  Curr Top Microbiol Immunol       Date:  1994       Impact factor: 4.291

6.  Detection of human papilloma virus DNA in lymph nodes extirpated at radical surgery for cervical cancer is not predictive of recurrence.

Authors:  J Czeglédy; C Iosif; O Forslund; R Willén; B G Hansson
Journal:  J Med Virol       Date:  1998-03       Impact factor: 2.327

7.  Relationship between human papillomavirus infection and overexpression of p53 protein in cervical carcinomas and lymph node metastases.

Authors:  S Cavuslu; J Goodlad; C Hobbs; A M Connor; K S Raju; J M Best; J Cason
Journal:  J Med Virol       Date:  1997-10       Impact factor: 2.327

8.  Determinants of increased risk for recurrence in patients undergoing radical hysterectomy for stage IB and IIA carcinoma of the cervix.

Authors:  A F Fuller; N Elliott; C Kosloff; W J Hoskins; J L Lewis
Journal:  Gynecol Oncol       Date:  1989-04       Impact factor: 5.482

9.  Human papillomavirus DNA in distant metastases of cervical cancer.

Authors:  H Ikenberg; G Teufel; B Schmitt; F Kommoss; B Stanimirovic; A Pfleiderer
Journal:  Gynecol Oncol       Date:  1993-01       Impact factor: 5.482

10.  Amplification of human papillomavirus type 16 transforming genes from cervical cancer biopsies and lymph nodes of Hungarian patients.

Authors:  J Czeglédy; R Póka; G Veress; L Gergely
Journal:  J Clin Microbiol       Date:  1992-01       Impact factor: 5.948

View more
  5 in total

Review 1.  Usefulness, methods and rationale of lymph nodes HPV-DNA investigation in estimating risk of early stage cervical cancer recurrence: a systematic literature review.

Authors:  Marco Noventa; Emanuele Ancona; Erich Cosmi; Carlo Saccardi; Pietro Litta; Donato D'Antona; Giovanni Battista Nardelli; Salvatore Gizzo
Journal:  Clin Exp Metastasis       Date:  2014-07-20       Impact factor: 5.150

2.  Impact of tumor histology on detection of pelvic and para-aortic nodal metastasis with 18F-fluorodeoxyglucose-positron emission tomography in stage IB cervical cancer.

Authors:  Alexander J Lin; Jason D Wright; Farrokh Dehdashti; Barry A Siegel; Stephanie Markovina; Julie Schwarz; Premal H Thaker; David G Mutch; Matthew A Powell; Perry W Grigsby
Journal:  Int J Gynecol Cancer       Date:  2019-08-30       Impact factor: 3.437

3.  Detection of human papillomavirus type 16 in squamous cell carcinoma of the colon and its lymph node metastases with PCR and southern blot hybridization.

Authors:  Gábor Bognár; Gábor István; Bíborka Bereczky; Pál Ondrejka
Journal:  Pathol Oncol Res       Date:  2008-03-19       Impact factor: 3.201

4.  Serum microRNA-205 as a novel biomarker for cervical cancer patients.

Authors:  Quanhui Ma; Guiping Wan; Shuxia Wang; Wanwei Yang; Jiaming Zhang; Xiaoming Yao
Journal:  Cancer Cell Int       Date:  2014-08-22       Impact factor: 5.722

Review 5.  Importance of investigating high-risk human papillomavirus in lymph node metastasis of esophageal adenocarcinoma.

Authors:  Preeti Sharma; Shweta Dutta Gautam; Shanmugarajah Rajendra
Journal:  World J Gastroenterol       Date:  2020-06-07       Impact factor: 5.742

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.